Skip to content

Does salmon have BMAA? Latest research and expert insights

4 min read

According to a 2014 study published in Nature, BMAA was undetectable in the salmon samples tested from Swedish markets, offering reassurance to consumers. This initial finding helps address the crucial question: Does salmon have BMAA?

Quick Summary

Scientific investigations have consistently found BMAA, a neurotoxin from algae, to be undetectable in salmon samples. This is in stark contrast to filter-feeding mollusks, which can bioaccumulate the toxin.

Key Points

  • No BMAA Detected: Scientific studies, including a notable one in Nature, consistently found BMAA to be undetectable in salmon samples.

  • Algal Source: The neurotoxin BMAA is produced by cyanobacteria (blue-green algae), diatoms, and dinoflagellates at the base of the aquatic food chain.

  • Low Accumulation in Predators: Unlike filter-feeding shellfish like mussels and oysters, predatory salmon do not accumulate significant levels of BMAA.

  • Safe for Consumption: Given the lack of detectable BMAA, salmon remains a safe seafood choice regarding this specific neurotoxin, according to expert analysis.

  • Varying Risk by Species: The risk of BMAA contamination depends on the seafood type and its feeding habits, with bottom-dwelling, filter-feeding mollusks being the primary concern.

  • Analytical Consistency: Consistent findings across modern, selective analytical methods provide a reliable basis for the conclusion that salmon lacks detectable BMAA.

In This Article

What is BMAA and why is it a concern?

β-N-methylamino-L-alanine (BMAA) is a naturally occurring neurotoxin produced primarily by certain types of cyanobacteria, also known as blue-green algae. It has also been detected in diatoms and dinoflagellates. Cyanobacterial blooms are becoming more frequent globally due to nutrient pollution, leading to concerns about BMAA entering aquatic ecosystems and the food chain. BMAA has been linked in some controversial studies and animal models to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Parkinson's, and Alzheimer's, although a direct causal link in humans remains unproven. The hypothesis suggests that chronic exposure, even at low levels, could contribute to disease development, raising public health concerns. However, the reliability of early analytical methods for detecting BMAA has been debated, making accurate quantification a challenge. Newer, more sensitive methods are now used, but historical discrepancies underscore the importance of careful scientific reporting.

The origin of BMAA

BMAA originates from several types of micro-organisms found in various aquatic and terrestrial environments. These include:

  • Cyanobacteria: Ubiquitous in freshwater, marine, and terrestrial habitats, cyanobacteria are the most recognized producers of BMAA. Their toxins can accumulate during harmful algal blooms.
  • Diatoms: These single-celled eukaryotic algae are also capable of producing BMAA and its isomers, contributing to the toxin's presence in marine and freshwater systems.
  • Dinoflagellates: A group of plankton, some species have been found to produce BMAA, adding another source to the aquatic environment.

The search for BMAA in seafood

Due to the presence of BMAA in phytoplankton, scientists have investigated its potential to transfer and bioaccumulate up the food chain, ultimately reaching seafood consumed by humans. Studies have examined a variety of commercial seafood sold in metropolitan markets to assess dietary exposure risks. Results have shown varying degrees of BMAA accumulation depending on the species' trophic level and feeding behavior. Filter-feeding shellfish like mussels and oysters are known to accumulate BMAA because they feed directly on the plankton that produce the toxin. In contrast, research has consistently failed to detect BMAA in certain predatory fish species.

Key scientific findings on salmon

When analyzed using highly sensitive and selective methods like UPLC-MS/MS, multiple studies have specifically reported that BMAA was not detected in salmon. A 2014 study from Stockholm University, for instance, systematically screened for BMAA in popular commercial seafood and reported that while BMAA was found in mussels, oysters, and shrimp, it was undetectable in salmon, cod, and perch. A press release from the university later confirmed this result, reassuring consumers about the low risk from certain commercial seafood. These findings align with similar data cited in a 2018 review on the occurrence of BMAA, which also noted the non-detection in salmon.

Why salmon is typically BMAA-free

The difference in BMAA levels between salmon and other seafood, such as filter-feeders, is primarily attributed to their diet and position in the food web. Salmon are predatory fish that consume smaller fish and invertebrates rather than filter-feeding directly on plankton, which are the initial producers of BMAA. This places salmon at a higher trophic level, but their specific feeding habits likely reduce their overall exposure compared to species that continuously filter water containing BMAA-producing micro-organisms. While BMAA can biomagnify in some food chains, studies have shown that it may not do so effectively in all aquatic ecosystems or species, especially compared to persistent organic pollutants that accumulate in fatty tissues.

Comparative analysis: Salmon vs. filter-feeders regarding BMAA

Feature Salmon (Predatory Fish) Mussels, Oysters (Filter-feeders)
Diet Consumes smaller fish and crustaceans. Feeds directly on plankton, including BMAA-producing cyanobacteria, diatoms, and dinoflagellates.
Trophic Level Higher trophic level predator. Lower trophic level, primary consumer.
BMAA Levels Consistently found to have undetectable levels in modern studies. Regularly detected due to filtering large volumes of water containing BMAA producers.
Risk of Accumulation Low risk based on current scientific evidence, diet, and metabolic pathways. Higher risk of bioaccumulation, though levels are monitored for public health.
Primary Producer Exposure Indirectly exposed via prey, but bioaccumulation is not evident. Directly consumes BMAA-producing micro-organisms.

Research inconsistencies and analytical challenges

It is important to acknowledge the complexities of BMAA research. Historical and ongoing studies have produced variable and sometimes conflicting results regarding the presence and concentration of BMAA in environmental samples and organisms. This variation can be due to a multitude of factors, including the specific cyanobacterial strains present, environmental conditions that influence toxin production (like nitrogen levels), and particularly, the analytical methods used for detection. Early detection methods based on fluorescence were less selective and potentially prone to misidentification compared to modern mass spectrometry techniques. Consequently, some previous studies may have produced false positive or over-estimated results. However, findings from studies using today's more reliable methods provide the most accurate picture, confirming the low likelihood of BMAA in salmon.

Conclusion: The current outlook on salmon and BMAA

Based on current scientific evidence from reliable analytical studies, consumers can be confident that commercially available salmon does not contain detectable levels of BMAA. While BMAA is a valid concern in certain other seafood, particularly filter-feeding mollusks, salmon's position as a predatory fish minimizes its risk of accumulating this specific neurotoxin. Ongoing research continues to shed light on the complex dynamics of BMAA in aquatic food webs, but the data on salmon remain consistently reassuring. For those concerned about seafood toxins, understanding the difference in accumulation pathways between different species is key to making informed dietary choices. Further information on marine neurotoxins is available from sources like the U.S. Environmental Protection Agency.

Note: While BMAA risk from salmon is negligible, other seafood-related health concerns, like mercury levels in certain fish, should be considered as part of a balanced diet.

Frequently Asked Questions

BMAA is a neurotoxic amino acid produced by cyanobacteria (blue-green algae), diatoms, and dinoflagellates. It is under investigation for its potential links to neurodegenerative diseases.

Scientific studies have already found BMAA to be undetectable in salmon, so no removal process is necessary. However, for other seafood, it is important to note that cooking or freezing does not destroy BMAA or other heat-stable toxins.

Yes, studies have detected BMAA in filter-feeding mollusks like blue mussels and oysters, which consume the algae that produce the toxin. Some shellfish and other fish have also shown detectable levels.

Discrepancies in older research can be attributed to differences in analytical methods, the organisms tested, and reporting errors. Modern studies using more selective and sensitive techniques are considered more reliable.

Regardless of whether it is wild-caught or farm-raised, scientific studies have shown BMAA to be undetectable in salmon. The risk profile is considered consistently low based on the organism's feeding habits, which do not involve filtering the plankton that produce BMAA.

Based on current scientific evidence, there is no need to be concerned about BMAA when eating salmon. Salmon does not appear to accumulate this neurotoxin and is considered a safe choice in this regard.

BMAA, produced by micro-algae at the base of the food web, can be consumed by filter-feeders like mussels and oysters. The toxin can then potentially transfer to higher trophic levels, although this process, known as bioaccumulation, does not appear to result in detectable BMAA in salmon.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.